Zai Lab Limited (ZLAB)
USD 31.63
(-13.8%)
USD 31.63
(-13.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -775 Million USD | 21.56% |
| 2022 | -988.07 Million USD | -4.17% |
| 2021 | -948.56 Million USD | -123.97% |
| 2020 | -423.51 Million USD | -682.06% |
| 2019 | -54.15 Million USD | 8.69% |
| 2018 | -59.3 Million USD | 74.18% |
| 2017 | -229.66 Million USD | -173.57% |
| 2016 | -83.94 Million USD | -537.87% |
| 2015 | -13.16 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -587.43 Million USD | 24.2% |
| 2024 Q2 | -646.36 Million USD | 6.99% |
| 2023 Q2 | -840.1 Million USD | 2.26% |
| 2023 FY | -775 Million USD | 21.56% |
| 2023 Q1 | -859.54 Million USD | 13.01% |
| 2023 Q4 | -775 Million USD | -0.37% |
| 2023 Q3 | -772.11 Million USD | 8.09% |
| 2022 Q4 | -988.07 Million USD | 10.06% |
| 2022 FY | -988.07 Million USD | -4.17% |
| 2022 Q1 | -829.06 Million USD | 12.6% |
| 2022 Q2 | -661.03 Million USD | 20.27% |
| 2022 Q3 | -1.09 Billion USD | -66.19% |
| 2021 FY | -948.56 Million USD | -123.97% |
| 2021 Q4 | -948.56 Million USD | 31.34% |
| 2021 Q3 | -1.38 Billion USD | 20.98% |
| 2021 Q2 | -1.74 Billion USD | -75.61% |
| 2021 Q1 | -995.51 Million USD | -135.06% |
| 2020 Q4 | -423.51 Million USD | 0.0% |
| 2020 FY | -423.51 Million USD | -682.06% |
| 2020 Q1 | 275.93 Million USD | 609.53% |
| 2020 Q2 | -239.73 Million USD | -186.88% |
| 2019 Q4 | -54.15 Million USD | -13.17% |
| 2019 FY | -54.15 Million USD | 8.69% |
| 2019 Q3 | -47.85 Million USD | 38.84% |
| 2019 Q1 | -81.13 Million USD | -36.8% |
| 2019 Q2 | -78.23 Million USD | 3.57% |
| 2018 Q1 | -126.95 Million USD | 44.72% |
| 2018 FY | -59.3 Million USD | 74.18% |
| 2018 Q4 | -59.3 Million USD | 0.0% |
| 2018 Q2 | -126.95 Million USD | 0.0% |
| 2017 Q3 | -229.66 Million USD | -148.11% |
| 2017 Q1 | -92.56 Million USD | -10.26% |
| 2017 Q2 | -92.56 Million USD | 0.0% |
| 2017 FY | -229.66 Million USD | -173.57% |
| 2017 Q4 | -229.66 Million USD | 0.0% |
| 2016 Q1 | 13.16 Million USD | 0.0% |
| 2016 FY | -83.94 Million USD | -537.87% |
| 2016 Q4 | -83.94 Million USD | 0.0% |
| 2016 Q3 | -83.94 Million USD | 0.0% |
| 2015 FY | -13.16 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -1285.413% |
| Alkermes plc | -166.73 Million USD | -364.798% |
| Agenus Inc. | 274.13 Million USD | 382.706% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 141.445% |
| Aptorum Group Limited | 1.35 Million USD | 57209.339% |
| Ardelyx, Inc. | 34.51 Million USD | 2345.596% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 18207.477% |
| Bicycle Therapeutics plc | -481.46 Million USD | -60.966% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 2243.074% |
| ChromaDex Corporation | -24.04 Million USD | -3122.721% |
| Chimerix, Inc. | -25.51 Million USD | -2937.191% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 11222.152% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -3173.219% |
| CRISPR Therapeutics AG | -150.84 Million USD | -413.772% |
| Precision BioSciences, Inc. | -85.41 Million USD | -807.388% |
| Dyadic International, Inc. | -6.37 Million USD | -12050.956% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -4764.118% |
| Fortress Biotech, Inc. | 7.66 Million USD | 10210.894% |
| Lantern Pharma Inc. | -21.7 Million USD | -3470.889% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -601.123% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -8971.568% |
| Incyte Corporation | -3.17 Billion USD | 75.591% |
| IO Biotech, Inc. | -140.69 Million USD | -450.821% |
| Jaguar Health, Inc. | 29.39 Million USD | 2736.862% |
| Novavax, Inc. | -298.29 Million USD | -159.811% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 14621.267% |
| Opthea Limited | 28.15 Million USD | 2852.38% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -4516.118% |
| ContextLogic Inc. | -232 Million USD | -234.052% |
| MiMedx Group, Inc. | -33.9 Million USD | -2186.068% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 7701.766% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -33348.035% |
| NextCure, Inc. | -6.47 Million USD | -11865.416% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -1434.623% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -12049.24% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 6471.643% |
| Vaxcyte, Inc. | -368.22 Million USD | -110.468% |
| PDS Biotechnology Corporation | -32.7 Million USD | -2269.386% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 4585.473% |
| Pharming Group N.V. | 109.8 Million USD | 805.803% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -4355.047% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -342.276% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -4084.698% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -4084.698% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -10815.493% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -13125.256% |
| Acelyrin, Inc. | -216.9 Million USD | -257.303% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -13713.959% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -44853.596% |
| Summit Therapeutics Inc. | 34.67 Million USD | 2335.104% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -11292.033% |
| Senti Biosciences, Inc. | 1.74 Million USD | 44640.23% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -319.811% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -900.633% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -12684.56% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 776894.395% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 123507.643% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -562.133% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -360.671% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 799.017% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -10102.738% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -500.245% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 11340.684% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -219.768% |
| Immix Biopharma, Inc. | -17.5 Million USD | -4326.095% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -144.709% |
| MEI Pharma, Inc. | -3.7 Million USD | -20817.679% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 6294.549% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 579.158% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 2888.472% |
| Fortress Biotech, Inc. | 7.66 Million USD | 10210.894% |
| Precigen, Inc. | -481 Thousand USD | -161022.661% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 5603.87% |
| AlloVir, Inc. | -62.69 Million USD | -1136.202% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -1293.534% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 1356.77% |
| ImmuCell Corporation | 10.99 Million USD | 7151.505% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -402.77% |
| Onconetix, Inc. | 5.33 Million USD | 14636.419% |
| PureTech Health plc | -167.19 Million USD | -363.525% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -2444.32% |
| Elevation Oncology, Inc. | -19.11 Million USD | -3953.771% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -15687.329% |
| Seer, Inc. | -4.24 Million USD | -18178.302% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -3124.196% |
| Innoviva, Inc. | 255.56 Million USD | 403.252% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -1287.298% |
| ESSA Pharma Inc. | -33.62 Million USD | -2205.067% |
| GlycoMimetics, Inc. | -40.98 Million USD | -1790.962% |
| GT Biopharma, Inc. | -1.02 Million USD | -75805.975% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -1043.355% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 1365.162% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -478.017% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -5493.245% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -2584.262% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -1028651.958% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -2411.179% |
| Aptose Biosciences Inc. | -8.19 Million USD | -9357.151% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -24668.154% |
| Soligenix, Inc. | -4.95 Million USD | -15551.516% |
| Century Therapeutics, Inc. | 847 Thousand USD | 91599.41% |
| Kura Oncology, Inc. | -20.11 Million USD | -3752.272% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -1793.662% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -9128.388% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 42642.797% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -24141.476% |
| Autolus Therapeutics plc | -186.59 Million USD | -315.329% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -1471.881% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -181.007% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 2361.585% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 571.503% |
| GRI Bio, Inc. | -1.79 Million USD | -43099.554% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -8527.363% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -2230.336% |
| IGM Biosciences, Inc. | -72.6 Million USD | -967.405% |
| INmune Bio, Inc. | -25.41 Million USD | -2949.86% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 613.412% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1429.837% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -4669.415% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -26763.774% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 2138.669% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -1781.753% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 2530.61% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 305.053% |
| Verastem, Inc. | -37.27 Million USD | -1978.974% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -8441.827% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -1394.35% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -5020.581% |
| Histogen Inc. | -7.48 Million USD | -10251.276% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -3486.83% |
| Surrozen, Inc. | -32.66 Million USD | -2272.643% |
| Organovo Holdings, Inc. | -1.5 Million USD | -51326.676% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -18337.069% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 4187.508% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 29725.382% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 18747.738% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -9146.941% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -1683.988% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -5216.646% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -144.642% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -107231.801% |
| Apollomics, Inc. | -27.39 Million USD | -2728.983% |
| Amarin Corporation plc | -191.04 Million USD | -305.674% |
| Mesoblast Limited | 55.96 Million USD | 1484.844% |
| Turnstone Biologics Corp. | -14.58 Million USD | -5214.043% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -2964.21% |
| Synaptogenix, Inc. | -28.66 Million USD | -2603.976% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -82699.145% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 1690.331% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -89797.911% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -10565.999% |
| Exelixis, Inc. | -73.05 Million USD | -960.917% |
| Better Therapeutics, Inc. | -860 Thousand USD | -90016.279% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -3127.418% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -221.082% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 105389.471% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -10319.278% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 61902.233% |
| Gritstone bio, Inc. | 39.49 Million USD | 2062.522% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -821.511% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -29343.723% |
| Avid Bioservices, Inc. | 169.72 Million USD | 556.613% |
| Insmed Incorporated | 721.62 Million USD | 207.397% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -8377.81% |
| MediWound Ltd. | -5.32 Million USD | -14462.195% |
| OmniAb, Inc. | 9.2 Million USD | 8521.167% |
| Alector, Inc. | -35.63 Million USD | -2074.706% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 1001.467% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -15626.461% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 5953.916% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 327.57% |
| Aura Biosciences, Inc. | -21.52 Million USD | -3500.465% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -839.622% |
| Immunic, Inc. | -45.34 Million USD | -1609.307% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -301.108% |
| Veracyte, Inc. | -203.82 Million USD | -280.23% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 221.418% |
| FibroGen, Inc. | 56.76 Million USD | 1465.23% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 8802.976% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -27313.425% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -37333.32% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 116.883% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -23096.648% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -366.969% |
| TG Therapeutics, Inc. | 17.86 Million USD | 4438.82% |
| Galecto, Inc. | -21.21 Million USD | -3552.903% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -3158.356% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 149.382% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -3066.885% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -6635.031% |
| XBiotech Inc. | -200.02 Million USD | -287.455% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -821.511% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 17215.724% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -2097.771% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -903.652% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 13717.993% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -354.772% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -738.981% |
| Vaxxinity, Inc. | 10.13 Million USD | 7749.033% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 205.261% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -7097.551% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -1075.026% |
| NexImmune, Inc. | -3.13 Million USD | -24631.598% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -22346.377% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -5028.561% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -2759.779% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -8534.084% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -622015.192% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -1810.184% |
| Ainos, Inc. | 4.07 Million USD | 19104.749% |
| Pluri Inc. | 22.82 Million USD | 3494.805% |
| Prothena Corporation plc | -608.34 Million USD | -27.394% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -552.599% |
| Celularity Inc. | 65.19 Million USD | 1288.833% |
| Rallybio Corporation | -24.1 Million USD | -3115.501% |
| Cue Biopharma, Inc. | -33.81 Million USD | -2191.611% |
| MeiraGTx Holdings plc | -40.3 Million USD | -1822.981% |
| Omeros Corporation | 331.17 Million USD | 334.015% |
| Humacyte, Inc. | -22.48 Million USD | -3346.589% |
| Immunocore Holdings plc | -358.59 Million USD | -116.122% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -3053.611% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -2408.009% |
| Blueprint Medicines Corporation | 702.83 Million USD | 210.268% |
| CalciMedica, Inc. | -5.53 Million USD | -13914.467% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -311.752% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -7487.625% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -1835.709% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -2230.617% |
| Pulmatrix, Inc. | -10.41 Million USD | -7339.762% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -12866.371% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -1931.881% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -595.679% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -1192.873% |
| Cytokinetics, Incorporated | 642.37 Million USD | 220.647% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -13209.291% |
| Nutriband Inc. | -251.65 Thousand USD | -307858.849% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -2171.462% |
| Vor Biopharma Inc. | 4.3 Million USD | 18123.256% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 87.16% |
| Evogene Ltd. | -19.63 Million USD | -3847.234% |
| ProKidney Corp. | -56.23 Million USD | -1278.121% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -1492.291% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -8290.0% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 156.822% |
| CorMedix Inc. | -43.05 Million USD | -1700.128% |
| BioLineRx Ltd. | 7.33 Million USD | 10664.34% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -2721.773% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 1779.416% |
| Atai Life Sciences N.V. | -28.55 Million USD | -2613.775% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 34845.121% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -3296.739% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 4469.89% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -932.315% |
| MediciNova, Inc. | -50.78 Million USD | -1426.086% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -883.44% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -3445110.047% |
| GeoVax Labs, Inc. | -6.45 Million USD | -11910.683% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -287.847% |
| Biomea Fusion, Inc. | -166.57 Million USD | -365.27% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -333.021% |
| Mereo BioPharma Group plc | -51.46 Million USD | -1405.761% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -717.131% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -163.822% |
| Absci Corporation | -72.59 Million USD | -967.523% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 17073.281% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -230.579% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -722.622% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -709.856% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -1883.467% |
| Allakos Inc. | -24.97 Million USD | -3003.103% |
| Imunon, Inc. | -4.21 Million USD | -18291.723% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -5157.089% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -472.378% |
| BioAtla, Inc. | -109.01 Million USD | -610.937% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 105389.471% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -82434.611% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 6576.684% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -3555.143% |
| XOMA Corporation | -29 Million USD | -2572.414% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -4579.952% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -8495.83% |
| aTyr Pharma, Inc. | -7.44 Million USD | -10304.081% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -521.811% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -272.303% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -847.676% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -735.462% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -90101.866% |
| Akari Therapeutics, Plc | -3.84 Million USD | -20056.047% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 47854.315% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 156.124% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -65128.278% |
| UroGen Pharma Ltd. | 4.39 Million USD | 17749.738% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 782.934% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 1077057.283% |
| Orgenesis Inc. | 21.78 Million USD | 3657.657% |
| Entera Bio Ltd. | -10.62 Million USD | -7191.373% |
| GH Research PLC | -78.07 Million USD | -892.61% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -3377.207% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -2807.086% |
| Xencor, Inc. | 29.64 Million USD | 2714.357% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -39243.856% |
| Replimune Group, Inc. | 1.41 Million USD | 54986.686% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -316345.359% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -513.05% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -65128.278% |
| Portage Biotech Inc. | -4.98 Million USD | -15459.125% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -3445110.047% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -1072.076% |
| OncoCyte Corporation | -6.56 Million USD | -11708.624% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 86459.346% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -16911.869% |
| Purple Biotech Ltd. | -14.13 Million USD | -5381.681% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -3162.334% |
| scPharmaceuticals Inc. | -6.54 Million USD | -11741.1% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -4542.897% |
| HilleVax, Inc. | -165.48 Million USD | -368.32% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -30435.855% |
| Tharimmune, Inc. | -10.93 Million USD | -6987.106% |
| Genprex, Inc. | -6.73 Million USD | -11402.563% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -110.137% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -776.102% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -55217.63% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -23264.866% |
| OKYO Pharma Limited | -826.84 Thousand USD | -93629.44% |
| Savara Inc. | 153 Thousand USD | 506635.948% |
| Curis, Inc. | -23.88 Million USD | -3144.443% |
| Daré Bioscience, Inc. | -5.15 Million USD | -14925.463% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -99769.59% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -12383.892% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 65500.844% |
| BeiGene, Ltd. | -2.25 Billion USD | 65.603% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 6381.152% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -27.424% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -317.596% |
| Erasca, Inc. | -37.21 Million USD | -1982.438% |
| bluebird bio, Inc. | 108.57 Million USD | 813.819% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -60075.807% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 304.622% |
| DBV Technologies S.A. | -126.98 Million USD | -510.303% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -60075.807% |
| Moderna, Inc. | -2.9 Billion USD | 73.34% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -7386.476% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -7031.027% |
| Molecular Templates, Inc. | 707 Thousand USD | 109718.105% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -2370.434% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 323.596% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -844.408% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -744.871% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -2301.463% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -2154.48% |
| MacroGenics, Inc. | -66.98 Million USD | -1056.975% |
| RenovoRx, Inc. | -1.17 Million USD | -65969.906% |
| Adicet Bio, Inc. | -138.78 Million USD | -458.41% |
| Prime Medicine, Inc. | -27.94 Million USD | -2673.702% |
| Aditxt, Inc. | 18.12 Million USD | 4376.833% |
| Adagene Inc. | -87.62 Million USD | -784.427% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -18505.531% |
| Quantum-Si incorporated | -118.55 Million USD | -553.694% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 2252.479% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -10269.019% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -1497.642% |
| SciSparc Ltd. | -2.06 Million USD | -37430.266% |
| Vericel Corporation | 1.27 Million USD | 60789.115% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -6362.803% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1990.048% |
| Generation Bio Co. | 31.44 Million USD | 2564.386% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -341.938% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -2406.225% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 764.705% |
| Invivyd, Inc. | -198.47 Million USD | -290.475% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -758.536% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -32222.801% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -994.787% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -11255.311% |
| 2seventy bio, Inc. | 181.71 Million USD | 526.492% |
| ADMA Biologics, Inc. | 90.06 Million USD | 960.48% |
| Clene Inc. | 3.34 Million USD | 23303.593% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -8432.702% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -3502.808% |
| GeoVax Labs, Inc. | -6.45 Million USD | -11910.683% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -125.21% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -2880.806% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 536.212% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -18841.398% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 15593.802% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -14778.096% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -494.763% |
| Evaxion Biotech A/S | 5.28 Million USD | 14759.029% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -588.473% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -490.373% |
| Trevena, Inc. | 2.25 Million USD | 34422.409% |
| Surrozen, Inc. | -32.66 Million USD | -2272.643% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -1404.562% |
| Cingulate Inc. | 3.08 Million USD | 25240.438% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -26287.47% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 10883.359% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -8241.202% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -877.018% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -489.569% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -634.305% |
| Clearmind Medicine Inc. | -3.94 Million USD | -19556.895% |
| Kronos Bio, Inc. | -36.05 Million USD | -2049.554% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 8336.795% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 53250.377% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -1328.413% |
| Statera Biopharma, Inc. | 14.41 Million USD | 5475.82% |
| ImmunityBio, Inc. | 618.22 Million USD | 225.359% |
| Korro Bio, Inc. | -132.94 Million USD | -482.957% |
| Kineta, Inc. | -4.54 Million USD | -16966.725% |
| BioVie Inc. | -17.73 Million USD | -4270.543% |
| Codexis, Inc. | -43.27 Million USD | -1691.038% |
| Celularity Inc. | 65.19 Million USD | 1288.833% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -24355.664% |
| Celcuity Inc. | 6.78 Million USD | 11524.766% |
| Virax Biolabs Group Limited | -3.36 Million USD | -22931.587% |
| Cibus, Inc. | -8.07 Million USD | -9493.959% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -18225.845% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 17058.425% |
| IN8bio, Inc. | -16.38 Million USD | -4628.781% |
| Kodiak Sciences Inc. | -103.87 Million USD | -646.089% |
| Annexon, Inc. | -193.75 Million USD | -299.99% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 2152877.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -4328.825% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -21960.917% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 173.51% |
| Eyenovia, Inc. | 1.25 Million USD | 61671.365% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 2980.505% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -23797.626% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -2231.037% |
| Arcellx, Inc. | -296.95 Million USD | -160.98% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -3873.136% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -1216.348% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -3639.084% |
| Moolec Science SA | 117.61 Thousand USD | 659023.956% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -1918.282% |
| Geron Corporation | 14.76 Million USD | 5350.322% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -1943.884% |
| Royalty Pharma plc | 5.65 Billion USD | 113.697% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -448.009% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -10988.181% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -14351.247% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -450.696% |
| Humacyte, Inc. | -22.48 Million USD | -3346.589% |
| Structure Therapeutics Inc. | -124.33 Million USD | -523.296% |
| 89bio, Inc. | -289.05 Million USD | -168.117% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -2970.28% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -43366.068% |
| Genelux Corporation | -6.89 Million USD | -11133.512% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -2395.251% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 1027.045% |
| Notable Labs, Ltd. | -9.77 Million USD | -7827.578% |
| Liquidia Corporation | -80.17 Million USD | -866.623% |
| Mustang Bio, Inc. | -3.73 Million USD | -20644.111% |
| Immunovant, Inc. | -635.22 Million USD | -22.004% |
| Quantum-Si incorporated | -118.55 Million USD | -553.694% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -4312.435% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -18606.252% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 9754.915% |
| Acasti Pharma Inc. | -23 Million USD | -3268.833% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -22915.958% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -4669.415% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -462.654% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -24768.741% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -3385.966% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -4073.623% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -357.827% |
| PepGen Inc. | -60.67 Million USD | -1177.402% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -3273.085% |
| United Therapeutics Corporation | -507.7 Million USD | -52.649% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -3952.076% |
| Solid Biosciences Inc. | -47.75 Million USD | -1523.037% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -89797.911% |
| Immuneering Corporation | -54.94 Million USD | -1310.556% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -18337.069% |
| Silo Pharma, Inc. | -3.52 Million USD | -21890.133% |
| Belite Bio, Inc | -87.27 Million USD | -788.038% |
| XOMA Corporation | -29 Million USD | -2572.414% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -996.228% |
| Bionomics Limited | 227 Million USD | 441.395% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -566.483% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -30496.131% |
| uniQure N.V. | -102.95 Million USD | -652.785% |
| Cassava Sciences, Inc. | -121.13 Million USD | -539.777% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -18505.531% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1992.506% |
| Forte Biosciences, Inc. | -11.96 Million USD | -6379.391% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -24946.862% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 731232.075% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -23797.626% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 8802.976% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -10350.378% |
| Altimmune, Inc. | -134.48 Million USD | -476.264% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 491.286% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -30496.131% |
| Compugen Ltd. | -12.9 Million USD | -5905.89% |
| Peak Bio, Inc. | 10.34 Million USD | 7595.05% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -273751.59% |
| Benitec Biopharma Inc. | -50.58 Million USD | -1432.166% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -642.778% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 4045.024% |
| Zura Bio Limited | -99.8 Million USD | -676.506% |
| PolyPid Ltd. | 6.17 Million USD | 12660.778% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 1145.602% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 4045.024% |
| Instil Bio, Inc. | 75.35 Million USD | 1128.424% |
| argenx SE | -2.02 Billion USD | 61.801% |
| Immunome, Inc. | -97.02 Million USD | -698.73% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -3345.21% |
| Verona Pharma plc | -220.44 Million USD | -251.565% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -980.245% |
| Shattuck Labs, Inc. | -121.42 Million USD | -538.259% |
| CervoMed Inc. | -7.79 Million USD | -9845.019% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -317.792% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -17622.387% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -488.28% |
| Moolec Science SA | 117.61 Thousand USD | 659023.956% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -33772.718% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 4974.711% |
| AnaptysBio, Inc. | -18.15 Million USD | -4169.737% |
| Design Therapeutics, Inc. | -18.15 Million USD | -4169.972% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -1001.149% |
| NeurAxis, Inc. | 145.7 Thousand USD | 532014.894% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 6999.929% |
| Lumos Pharma, Inc. | -28.49 Million USD | -2619.966% |
| Achilles Therapeutics plc | -126.92 Million USD | -510.602% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -980.245% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -118088.889% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -3630.656% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 53250.377% |
| Nutriband Inc. | -251.65 Thousand USD | -307858.849% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -5784.139% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -10316.667% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 327.809% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 3365.22% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -73.195% |
| Palisade Bio, Inc. | -12.06 Million USD | -6324.604% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -452.344% |
| Beam Therapeutics Inc. | -262.72 Million USD | -194.989% |
| Neurogene Inc. | -131.95 Million USD | -487.321% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 3652.439% |
| AEON Biopharma, Inc. | -4.88 Million USD | -15781.148% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -105.466% |
| Sesen Bio, Inc. | -112.55 Million USD | -588.564% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -676.087% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -32909.724% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -1885.856% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -830.573% |
| Athira Pharma, Inc. | -88.99 Million USD | -770.796% |
| Vaccinex, Inc. | -1.28 Million USD | -60070.807% |
| HCW Biologics Inc. | 2.85 Million USD | 27229.433% |
| XOMA Corporation | -29 Million USD | -2572.414% |
| Nektar Therapeutics | 210.24 Million USD | 468.626% |
| Arvinas, Inc. | -313.8 Million USD | -146.973% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 47854.315% |
| Merus N.V. | -192.88 Million USD | -301.796% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 1391.99% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -11070.366% |
| Rezolute, Inc. | -68.16 Million USD | -1036.897% |
| Clene Inc. | 3.34 Million USD | 23303.593% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -5777.0% |
| BeyondSpring Inc. | -13.75 Million USD | -5534.315% |
| Synlogic, Inc. | -6.68 Million USD | -11493.119% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 68442.152% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -9066.174% |
| Peak Bio, Inc. | 10.34 Million USD | 7595.05% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -840.306% |
| Krystal Biotech, Inc. | -350.23 Million USD | -121.281% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 724.371% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -358.591% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -24447.502% |
| MannKind Corporation | 143.89 Million USD | 638.572% |
| Ikena Oncology, Inc. | -109.15 Million USD | -609.993% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -10136.428% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -2241.39% |
| Gossamer Bio, Inc. | 180.35 Million USD | 529.708% |
| CohBar, Inc. | -5.93 Million USD | -12967.529% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -2505.217% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 17073.281% |
| Legend Biotech Corporation | -949.39 Million USD | 18.369% |
| Mural Oncology plc | -255.84 Million USD | -202.92% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 2505.712% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -16352.11% |
| Disc Medicine, Inc. | -358.28 Million USD | -116.311% |
| Champions Oncology, Inc. | 4.81 Million USD | 16205.569% |
| REGENXBIO Inc. | 54.76 Million USD | 1515.06% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -288103.728% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -413.163% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -8499.639% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -860.549% |
| Vaxart, Inc. | -8.24 Million USD | -9304.199% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -1444.441% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -509.441% |
| Cellectis S.A. | -43.85 Million USD | -1667.187% |
| Longeveron Inc. | -2.9 Million USD | -26550.619% |
| Repare Therapeutics Inc. | -107.85 Million USD | -618.537% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 180.031% |
| Inozyme Pharma, Inc. | 12 Million USD | 6556.181% |
| Revolution Medicines, Inc. | -608.2 Million USD | -27.424% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -62908.13% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -192.324% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -416.419% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -4853.026% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -104629.73% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 91.897% |
| Denali Therapeutics Inc. | -74.86 Million USD | -935.197% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -6362.803% |
| Veru Inc. | 4.77 Million USD | 16313.494% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -6791.339% |
| Cingulate Inc. | 3.08 Million USD | 25240.438% |
| Passage Bio, Inc. | 4.58 Million USD | 17002.944% |
| Context Therapeutics Inc. | -14.44 Million USD | -5263.386% |
| Exicure, Inc. | 5.84 Million USD | 13350.128% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -236.407% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -1858.554% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 5039.137% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -1217.557% |
| Nuvalent, Inc. | -335.38 Million USD | -131.076% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 44785.561% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -940.52% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -8617.66% |
| OmniAb, Inc. | 9.2 Million USD | 8521.167% |
| Anew Medical, Inc. | 1.43 Million USD | 54202.544% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 4830.873% |
| Lipocine Inc. | -4.75 Million USD | -16200.032% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -605.649% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 5188.307% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1429.837% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 3213.45% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -11431.022% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -1077.328% |
| Ocugen, Inc. | -32.52 Million USD | -2283.076% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -805.638% |
| Q32 Bio Inc. | -37.94 Million USD | -1942.268% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -123307.643% |
| Alumis Inc. Common Stock | -13.52 Million USD | -5628.435% |
| Equillium, Inc. | -22.39 Million USD | -3361.058% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -2931.133% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -2275.35% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -312507.144% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 678.177% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 24333.896% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 236063.232% |
| Dominari Holdings Inc. | 195 Thousand USD | 397535.897% |
| Edesa Biotech, Inc. | -5.26 Million USD | -14614.51% |
| vTv Therapeutics Inc. | -8.91 Million USD | -8591.264% |
| Bio-Techne Corporation | 267.74 Million USD | 389.452% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -4681.294% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -556.257% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -9122.897% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -6025.998% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -216.173% |
| Nkarta, Inc. | 57.29 Million USD | 1452.554% |
| BioCardia, Inc. | 212 Thousand USD | 365666.038% |
| Iterum Therapeutics plc | 13.43 Million USD | 5867.227% |